Cambria Investment Management, L.P. Corbus Pharmaceuticals Holdings, Inc. Transaction History

Cambria Investment Management, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 04, 2021	SELL	$0.94 - $1.89 $41,256 - $82,952	-43,890 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$1.5 - $9.38 $12,540 - $78,416	8,360 Added 23.53%	43,890 $79,000
Q2 2020 Aug 10, 2020	BUY	$4.79 - $8.39 $10,011 - $17,535	2,090 Added 6.25%	35,530 $298,000
Q1 2020 May 15, 2020	BUY	$3.44 - $7.21 $14,379 - $30,137	4,180 Added 14.29%	33,440 $175,000
Q4 2019 Feb 12, 2020	BUY	$4.29 - $5.64 $44,830 - $58,938	10,450 Added 55.56%	29,260 $160,000
Q3 2019 Nov 13, 2019	BUY	$4.87 - $7.08 $91,604 - $133,174	18,810 New	18,810 $92,000

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $1.63B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Cambria Investment Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Cambria Investment Management, L.P. with notifications on news.